A.P. Pharma to Present at Merriman Curhan Ford ''Investor Summit 2006'' on September 18.REDWOOD CITY Redwood City, city (1990 pop. 66,072), seat of San Mateo co., W Calif., on San Francisco Bay; inc. 1868. Manufactures include commmunications, electrical, electronic, and medical equipment. , Calif. -- A.P. Pharma, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :APPA), a specialty pharmaceutical company, today announced it will present at the Merriman Curhan Ford "Investor Summit 2006" to be held September 18-20 at the Mark Hopkins Hotel in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden . Dr. Paul Goddard This article is about an English footballer. For the Australian actor of the same name, see Paul Goddard (actor). Paul Goddard (b. 12 October, 1959 in Harlington, Middlesex) is a former professional footballer and football manager. , A.P. Pharma's chairman, is scheduled to speak on Monday, September 18, at 4:00 p.m. Pacific time (7:00 p.m. Eastern time) and will discuss the Company's strategic initiatives and provide a business update. Interested parties can access a live audio webcast at www.appharma.com. An archived presentation will be available on the Web site for 30 days. About A.P. Pharma A.P. Pharma is a specialty pharmaceutical company focused on the development of ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The Company's primary focus is the development and commercialization of its bioerodible injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. and implantable systems under the trade name Biochronomer. Initial target areas of application for the Company's drug delivery technology include anti-nausea, pain management, anti-inflammation and DNA/RNAI applications. For further information visit the Company's web site at www.appharma.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion